CAS 2245255-66-5
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt
CAS :Formule :C21H33F3N8O7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :566.5313GSK2807 Trifluoroacetate
CAS :GSK2807 TrifluoroacetateDegré de pureté :≥98%Masse moléculaire :566.53g/molGSK2807 Trifluoroacetate
CAS :GSK2807 Trifluoroacetate is a selective and SAM-competitive inhibitor of SMYD3 (Ki: 14 nM; IC50: 130 nM).Formule :C21H33F3N8O7Degré de pureté :99.95%Couleur et forme :SolidMasse moléculaire :566.53(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt
CAS :Degré de pureté :98%Masse moléculaire :566.5390015GSK2807 Trifluoroacetate
CAS :<p>GSK2807 Trifluoroacetate is a selective inhibitor, specifically targeting the lysine acetyltransferase MYST3 (MOZ), which is derived synthetically through medicinal chemistry. This compound functions by competitively inhibiting the acetylation of histone lysine residues, crucial components in the regulation of gene expression through chromatin modification. The inhibition of MYST3 disrupts its role in facilitating transcriptional activation by modulating chromatin structure, thereby impairing the recruitment of transcription factors and other co-regulatory proteins essential for gene expression.</p>Formule :C21H33F3N8O7Degré de pureté :Min. 95%Masse moléculaire :566.53 g/mol
